Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Plewiska k. Poznania

18 clinical trials in Plewiska k. Poznania, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Plewiska k. Poznania at a glance
18
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

18 trials in Plewiska k. Poznania

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE
  • Sponsor:Maplight Therapeutics Inc.
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:5-[(1R,5R)-3-AZABICYCLO[3.1.0]HEXAN-1-YL]-3-METHYL-1,2,4-OXADIAZOLE
  • Sponsor:Maplight Therapeutics Inc.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Vidofludimus Calcium
  • Sponsor:Immunic AG
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Teriflunomide
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Methylprednisolone
  • Sponsor:Celltrion Inc.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Fenebrutinib
  • Sponsor:F. Hoffmann-La Roche AG

Multiple sclerosis

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Multiple sclerosis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Fenebrutinib
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Plewiska k. Poznania

What the registry says about research in the country

01 Multiple Sclerosis Research

Groundbreaking clinical trials focusing on relapsing forms of multiple sclerosis, evaluating novel therapeutic approaches and comparing treatment efficacies. Studies aim to assess new medications against established treatments for better patient outcomes.

  • Relapsing MS Treatment Evaluation
  • Serum Biomarker Analysis
  • Disease Progression Assessment

Research includes innovative treatments targeting neurological markers and disability progression reduction.

02 Progressive MS Studies

Dedicated research examining Primary Progressive Multiple Sclerosis (PPMS), with trials evaluating higher-dose treatment protocols and their impact on disease progression.

  • Disability Progression Monitoring
  • Advanced Treatment Protocols
  • Long-term Efficacy Assessment

Investigations focus on improving treatment outcomes for progressive forms of MS through innovative therapeutic approaches.

03 Comparative Treatment Studies

Clinical trials comparing different therapeutic interventions for multiple sclerosis, including established and novel treatments to determine optimal patient care strategies.

  • Treatment Efficacy Comparison
  • Relapse Rate Analysis
  • Safety Profile Assessment

Research emphasizes measuring treatment effectiveness through various clinical endpoints and patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.